Whatsapp 93125-11015 For Details

Daily Current Affairs for UPSC Exam

14Oct
2024

India Achieves Milestone: WHO Declares Country Trachoma-Free (GS Paper 2, Health)

India Achieves Milestone: WHO Declares Country Trachoma-Free (GS Paper 2, Health)

Context

  • In a significant public health triumph, the World Health Organization (WHO) has officially declared India free from trachoma, making it the third country in the South-East Asia Region to reach this milestone.
  • This achievement not only reflects India’s dedication to improving health outcomes but also highlights the effectiveness of strategic public health initiatives.

 

What is Trachoma?

  • Trachoma is an infectious disease caused by the bacterium Chlamydia trachomatis.
  • It is the leading infectious cause of blindness globally and primarily affects vulnerable populations, especially young children.
  • The disease spreads through direct or indirect contact with infected eye or nasal discharges, often in areas with poor sanitation and hygiene practices.

 

Symptoms and Complications

  • Initially, trachoma manifests as irritation and discomfort in the eyes.
  • However, repeated infections can lead to severe scarring of the eyelid (trachomatous trichiasis), where the eyelashes turn inward and rub against the eyeball, causing intense pain, corneal scarring, and eventual blindness.
  • Women are disproportionately affected due to their roles in caregiving, resulting in higher exposure to infected children.

 

Global Prevalence

  • WHO estimates that around 150 million people worldwide are affected by trachoma, with approximately 6 million at risk of blindness or severe visual impairment.
  • The disease remains endemic in rural regions of Africa, Asia, Central and South America, and the Middle East, with Africa being the most severely impacted continent.

 

Challenges in India

Historical Context

  • In India, trachoma has historically posed a significant challenge, particularly in specific states such as Punjab, Rajasthan, Western Uttar Pradesh, and parts of Uttarakhand.
  • During the 1970s, these regions reported prevalence rates exceeding 50%, making it a leading cause of blindness.
  • The disease frequently resurfaced in new communities, complicating eradication efforts.

 

Decline in Prevalence

  • By 2005, trachoma accounted for only 4% of blindness cases in India, largely due to targeted health interventions.
  • A national survey conducted in 2006-2007 indicated a significant decline in trachoma prevalence, prompting the government to further assess and address the situation in hyper-endemic areas.

 

Government Interventions

The Indian government has been proactive in combating trachoma through various initiatives:

National Trachoma Control Program

  • Launched in 1963, the National Trachoma Control Program aimed to reduce the incidence of trachoma through education, treatment, and hygiene promotion.
  • This program was later integrated into the broader National Program for Control of Blindness (NPCB).

 

Implementation of the SAFE Strategy

Following the WHO’s adoption of the SAFE strategy in 1993, India implemented comprehensive measures to combat trachoma:

  • Surgery: Providing surgical interventions for individuals suffering from trichiasis.
  • Antibiotics: Mass distribution of antibiotics, particularly azithromycin, to treat infections.
  • Facial Cleanliness: Promoting hygiene practices, such as regular face washing, to reduce transmission.
  • Environmental Improvements: Enhancing access to clean water and sanitation facilities, critical in preventing the spread of the disease.

By 2017, India was officially declared free from infective trachoma, but continued surveillance was established to monitor potential resurgence.

 

Role of National Initiatives

  • Programs like the Swachh Bharat Mission and Jal Jeevan Mission have played vital roles in improving sanitation and hygiene, further contributing to the elimination of trachoma.
  • These initiatives focus on providing access to clean drinking water and promoting cleanliness in communities, addressing the root causes of trachoma transmission.

 

Validation of Progress

  • To confirm the elimination status, the National Trachomatous Trichiasis Survey was conducted from 2021 to 2024 across 200 endemic districts, following WHO guidelines.
  • The results were meticulously compiled into a dossier and submitted to the WHO for validation.
  • After thorough evaluation, WHO officially recognized India’s efforts and declared the country trachoma-free.

 

Implications of the Declaration

The WHO's declaration carries profound implications for public health in India. It signifies:

  • Improved Public Health Status: The elimination of trachoma marks a critical improvement in India’s health indicators, particularly in areas related to water, sanitation, and hygiene (WASH).
  • "Gold-Tier" Health Achievement: India’s status is elevated to "gold-tier" public health, indicating significant progress in addressing major health challenges.
  • Global Health Leadership: This achievement positions India as a leader in global health efforts, serving as an example for other nations still grappling with trachoma and similar diseases.

Experts highlight that the elimination of trachoma is intrinsically linked to improved sanitation, a common issue in many developing countries. The successful eradication of trachoma underscores the importance of comprehensive approaches that address social determinants of health.

 

Conclusion

  • India’s achievement in eliminating trachoma reflects the effectiveness of targeted public health interventions and a sustained commitment to improving the health and well-being of its population.
  • This milestone not only celebrates the reduction of a debilitating disease but also sets a hopeful precedent for global health initiatives.
  • As India moves forward, this success serves as a reminder that with collaborative efforts and persistent focus, even the most challenging public health issues can be effectively addressed, paving the way for a healthier future.